Joseph Califano UCSD Cancer (@califanomd) 's Twitter Profile
Joseph Califano UCSD Cancer

@califanomd

Physician in Chief Moores Cancer Center, University of California, San Diego. Surgeon. Researcher. Note: All opinions are my own

ID: 1057002694961819651

calendar_today29-10-2018 20:14:15

92 Tweet

572 Followers

136 Following

Joseph Califano UCSD Cancer (@califanomd) 's Twitter Profile Photo

We wanted to recognize Co-Director of the Gleiberman Head & Neck Cancer Center, Dr. Loren Mell for his appointment to the National Cancer Institute (NCI). Mell will serve as the Co-Chair of the Head and Neck Cancer Steering Committee National Cancer Institute UC San Diego Health Congrats Dr. Loren K. Mell

Joseph Califano UCSD Cancer (@califanomd) 's Twitter Profile Photo

Enjoyed publishing in the Journal of the @NCCN re: A Hospital-Wide Intervention to Improve Compliance With TNM Cancer Staging Documentation. Read more: pubmed.ncbi.nlm.nih.gov/34450596/

Joseph Califano UCSD Cancer (@califanomd) 's Twitter Profile Photo

One of our grateful patient stories is now airing across the nation. Please find the attached story regarding the impact that her journey has made as we continue to serve those in the field of head & neck oncology. @ivanhoenews UC San Diego News UC San Diego Health ivanhoe.com/medical-breakt…

Joseph Califano UCSD Cancer (@califanomd) 's Twitter Profile Photo

Register Today! Delivering Discoveries: Updates in Oncology October 29 – 30, 2021 Hyatt Regency La Jolla at Aventine Register here: cpd.ucsd.edu/oncology/regis… #oncology #cme #cancer #research #conference

UC San Diego Health Moores Cancer Center (@ucsdcancer) 's Twitter Profile Photo

The first in-person #DeliveringDiscoveries retreat since 2019 is next week! Program includes keynote addresses, breakthrough research presentations, a poster session, and a Shark Tank-like competition for a Scientific Retreat Pilot Project Award. Register: bit.ly/3S3TMxz

IFHNOS (@ifhnos_official) 's Twitter Profile Photo

IFHNOS Virtual World Tour (Eastern Hemisphere) on 12th November, 2022 | 9:30 am – 1 PM (IST). The program will provide state-of-art knowledge and explore the frontiers of Head & Neck cancer diagnosis, treatment through Keynote lectures and tumor boards. #IFHNOSWORLDTOUR2022

IFHNOS Virtual World Tour (Eastern Hemisphere) on 12th November, 2022 | 9:30 am – 1 PM (IST).
The program will provide state-of-art knowledge and explore the frontiers of Head & Neck cancer diagnosis, treatment through Keynote lectures and tumor boards. 
#IFHNOSWORLDTOUR2022
UC San Diego (@ucsandiego) 's Twitter Profile Photo

The Highly Cited Researchers list identifies exceptional researchers who are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers. #UCSanDiego ranks 8th in the world for 2022. bit.ly/3UX7Has

The Highly Cited Researchers list identifies exceptional researchers who are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers. #UCSanDiego ranks 8th in the world for 2022. bit.ly/3UX7Has
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) (@rbryanbell) 's Twitter Profile Photo

Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect- excited to explore this strategy in #HNSCC ⁦Nature Cancer⁩ ⁦Joseph Califano UCSD Cancer⁩ ⁦Ezra Cohen⁩ ⁦Rom Leidner⁩ ⁦GutkindLab⁩ ⁦Robert S-K nature.com/articles/s4301…

Joseph Califano UCSD Cancer (@califanomd) 's Twitter Profile Photo

Happy Holidays from UCSD Moores Cancer Center means a 3D confocal video of poinsettia pollen (green) on a pistil (red) taken by Califano lab member Riyam Al-Msari at consortium partner LJI…enjoy! #UCSD #MooresCancerCenter #LaJollaInstituteforImmunology

Christopher A. Longhurst, MD (@calonghurst) 's Twitter Profile Photo

The UC San Diego Health Moores Cancer Center team made 3 of the "23 oncology firsts" for 2022! #1 - preclinical model of appendiceal cancer #5 - advanced prostate cancer tx with Pluvicto #23 - employing high-intensity ultrasound as a minimally invasive prostate cancer treatment beckershospitalreview.com/oncology/23-on…

The <a href="/UCSDCancer/">UC San Diego Health Moores Cancer Center</a> team made 3 of the "23 oncology firsts" for 2022! 

#1 - preclinical model of appendiceal cancer

#5 - advanced prostate cancer tx with Pluvicto

#23 - employing high-intensity ultrasound as a minimally invasive prostate cancer treatment

beckershospitalreview.com/oncology/23-on…
Joseph Califano UCSD Cancer (@califanomd) 's Twitter Profile Photo

Scientists have a theory on covid loss of smell: Damage to nasal cells: great research by UCSD Otolaryngologist Carol Yan! washingtonpost.com/health/2022/12…

Ezra Cohen (@drezracohen) 's Twitter Profile Photo

Pleased to report our paper demonstrating that CD4s detect MHCII presented antigens on APCs not tumor cells. insight.jci.org/articles/view/…

Ankit Mangla, MD (@ankitmanglamd) 's Twitter Profile Photo

S1801. Practice changing data in high risk clinical stage 3 melanoma showing clear benefit in neoadjuavnt immunotherapy. Congratulations Sapna Patel SWOG Cancer Research Network on publishing the results in NEJM. nejm.org/doi/full/10.10…